Regulus Therapeutics (RGLS) Revenue & Revenue Breakdown
Regulus Therapeutics Revenue Highlights
00
Regulus Therapeutics Revenue by Period
Regulus Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $10.01M | 46.46% |
| 2019-12-31 | $6.83M | 9388.89% |
| 2018-12-31 | $72.00K | - |
| 2017-12-31 | $72.00K | -93.97% |
| 2016-12-31 | $1.19M | -94.25% |
| 2015-12-31 | $20.76M | 170.69% |
| 2014-12-31 | $7.67M | -60.81% |
| 2013-12-31 | $19.57M | 54.09% |
| 2012-12-31 | $12.70M | -7.90% |
| 2011-12-31 | $13.79M | 60.32% |
| 2010-12-31 | $8.60M | - |
Regulus Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Regulus Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $302.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $5.00M | - |
| 2020-09-30 | $5.00M | 100.00% |
| 2020-06-30 | - | -100.00% |
| 2020-03-31 | $6.00K | -66.67% |
| 2019-12-31 | $18.00K | - |
| 2019-09-30 | $18.00K | - |
| 2019-06-30 | $18.00K | -99.73% |
| 2019-03-31 | $6.78M | 37555.56% |
| 2018-12-31 | $18.00K | - |
| 2018-09-30 | $18.00K | - |
| 2018-06-30 | $18.00K | - |
| 2018-03-31 | $18.00K | - |
| 2017-12-31 | $18.00K | - |
| 2017-09-30 | $18.00K | - |
| 2017-06-30 | $18.00K | - |
| 2017-03-31 | $18.00K | - |
| 2016-12-31 | $18.00K | -91.18% |
| 2016-09-30 | $204.00K | -57.76% |
| 2016-06-30 | $483.00K | -1.23% |
| 2016-03-31 | $489.00K | -95.50% |
| 2015-12-31 | $10.86M | 482.31% |
| 2015-09-30 | $1.86M | -51.36% |
| 2015-06-30 | $3.83M | -8.71% |
| 2015-03-31 | $4.20M | -0.45% |
| 2014-12-31 | $4.22M | 289.57% |
| 2014-09-30 | $1.08M | 47.15% |
| 2014-06-30 | $736.00K | -54.87% |
| 2014-03-31 | $1.63M | -70.10% |
| 2013-12-31 | $5.45M | -10.85% |
| 2013-09-30 | $6.12M | 28.56% |
| 2013-06-30 | $4.76M | 46.97% |
| 2013-03-31 | $3.24M | - |
| 2012-12-31 | $3.24M | 15.27% |
| 2012-09-30 | $2.81M | -15.11% |
| 2012-06-30 | $3.31M | -1.05% |
| 2012-03-31 | $3.34M | -0.56% |
| 2011-12-31 | $3.36M | -11.71% |
| 2011-09-30 | $3.81M | - |
Regulus Therapeutics generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Regulus Therapeutics Revenue Breakdown
Regulus Therapeutics Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Mar 20 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|
| Strategic Alliances and Collaborations | $6.00K | $18.00K | $18.00K | $6.78M | $18.00K | $18.00K |
Latest
Regulus Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Mar 20: Strategic Alliances and Collaborations (100.00%).
Regulus Therapeutics Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Mar 20 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|
| Strategic Alliances and Collaborations | $6.00K | $18.00K | $18.00K | $6.78M | $18.00K | $18.00K |
Latest
Regulus Therapeutics's latest quarterly revenue breakdown by geography, as of Mar 20: Strategic Alliances and Collaborations (100.00%).